Arctic Wolf vs Verkada: employee equity compared
Secondary market prices, valuation trajectory, equity structure, and liquidity outlook for employees choosing between Arctic Wolf and Verkada.
Arctic Wolf
Managed Detection and Response (MDR) platform that combines 24/7 SOC-as-a-service with proprietary threat intelligence — a security operations centre delivered as a subscription.
IPO possible 2027–2029 once ARR milestones are hit. Strategic M&A also plausible in consolidating sector.
High NRR cybersecurity; ISO/NSO options; strategic M&A common at scale
Verkada
Cloud-managed physical security platform combining AI-powered cameras, access control, alarms, and environmental sensors on a unified SaaS dashboard.
IPO possible 2027–2029 once ARR milestones are hit. Strategic M&A also plausible in consolidating sector.
High NRR cybersecurity; ISO/NSO options; strategic M&A common at scale
Key differences for employees
Equity structure
Arctic Wolf grants ISO/NSO with strike prices ranging from $14–$22 depending on your grant year. Verkada grants ISO/NSO with strike prices from $14–$22.
Secondary market premium
The secondary market is pricing Arctic Wolf at a +2% premium over its last primary round ($4.3B → $4.4B). Verkada trades at +3% over its last round ($3.2B → $3.3B). A higher secondary premium signals stronger investor demand and potentially better near-term liquidity for employees looking to sell.
Revenue and growth
Arctic Wolf runs at $0.5B ARR, growing +35% YoY (solid). Verkada runs at $0.3B ARR, growing +40% YoY (solid). Revenue growth rate matters for equity because it drives the peer-multiple valuation — the method most correlated with exit multiples.
Liquidity timeline
Arctic Wolf: IPO possible 2027–2029 once ARR milestones are hit. Strategic M&A also plausible in consolidating sector.
Verkada: IPO possible 2027–2029 once ARR milestones are hit. Strategic M&A also plausible in consolidating sector.
Calculate your specific grant
Enter your actual shares, equity type, and strike price. PrivatePulse calculates your personal equity value at both companies using 4 independent methods.